“Michael’s input was vital in helping us secure a $1.9 million grant. Syzent serves as co-investigator with responsibility for commercialization milestones and regulatory interactions. Syzent Partners refueled our research program.”
-Sylvain Martel PhD, Professor, École Polytechnique de Montréal and Director of the NanoRobotics Laboratory
“When you’re far apart on valuation, it’s a real challenge to bridge the gap. With the help of Syzent and Michael, we understood the objective technology value, and were able to negotiate a deal that was fair for both parties. Without Syzent, no deal. Syzent partners.”
-Anthony Giovinazzo, M.B.A., C.Dir., A.C.C., President, CEO & Director, Cynapsus Therapeutics Inc. (TSX-V: CTH)
“With their tenacity, work ethic and experience, Syzent opened doors for Université de Montréal and Univalor in multiple markets. Their professional work supported beautifully our need for a market assessment and beyond, and opened new commercialization opportunities for this diagnostic platform.”
-Louis Provencher, PhD, Manager Business Development, Univalor
“Syzent Partner’s guidance and value-added made an important contribution to the success of our $0.7 million grant application for highly multiplexed cellular imaging, in partnership with the neuroimaging laboratory of Dr. Paul De Koninck at Université Laval and of biosimulation partner Rhenovia Pharma Limited from Mulhouse, France.”
-Sébastien Blais-Ouellette, President & CEO, Photon etc. Inc.
“With Michael’s insightful commercial leadership, McGill’s novel CNS mechanism project advanced through multiple value-added steps, justifying continued research investment from private and public sources, including $0.7 million from MDEIE’s PSVT program.”
-Radu Pislariu MD, Investment Manager, MSBiV
“Michael Atkin scouted for and reviewed investment management opportunities for Kirschner, showing his resourcefulness and keen analytic skills. His input from potential LPs was extremely valuable.”
-Les Lyall, Managing Partner, Kirchner Portfolio Management Corp.